This joint project between Riverlane, Astex Pharmaceuticals and Rigetti Computing will develop an application for simulating molecular systems, paving the way for a commercial application that could transform drug development.
Riverlane is translating drug design problems into quantum computer programs optimised for Rigetti superconducting quantum processors. This project is funded by Innovate UK’s Industry Strategy Challenge Fund (ISCF).
